Arcus Biosciences adopts amended director compensation; annual meeting passes all proposals

Arcus Biosciences, Inc.

New non-employee director compensation: $45,000 annual cash retainer; $25,000 extra for Lead Independent Director.
Initial equity award: ~$750,000 grant-date value, 2/3 stock options and 1/3 RSUs, vesting over 3 years.
Annual equity award: ~$400,000 grant-date value, vests fully in 12 months or until next annual meeting.
Annual meeting results: all three Class III directors elected; Ernst & Young ratified; say-on-pay approved.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.